TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Mural Oncology Plc
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

Mural Oncology announced the final details of its acquisition by XRA 5 Corp., a subsidiary of XOMA Royalty, with a total cash consideration of $2.035 per share. The acquisition is expected to close in early December 2025, subject to Irish High Court sanction.

Insights
MURA   neutral

Being acquired at a predetermined price with no significant positive or negative indication of unexpected outcomes